NCT06257667View on ClinicalTrials.gov

Treatment of Acute Hypercapnic Respiratory Failure With OptiflowTM or Optiflow+DuetTM Nasal Cannula in COPD-patients

NANot yet recruitingINTERVENTIONAL

Enrollment

138

Participants

Timeline

Start Date

March 31, 2024

Primary Completion Date

September 30, 2025

Study Completion Date

February 28, 2026

Conditions

Hypercapnic Respiratory FailureCOPD

Interventions

OTHER

Respiratory Support

Treatment with High Flow Nasal Cannula

All Listed Sponsors

collaborator

Bispebjerg Hospital

OTHER

collaborator

Viborg Regional Hospital

OTHER

lead

Aalborg University Hospital

OTHER

NCT06257667 - Treatment of Acute Hypercapnic Respiratory Failure With OptiflowTM or Optiflow+DuetTM Nasal Cannula in COPD-patients | Biotech Hunter | Biotech Hunter